Extended Data Fig. 6: Brain Treg cells proliferate in response to IL-33.
From: Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery

a, The relative expression levels of Il33 in the ischaemic brains at the indicated time points after stroke onset were evaluated by qPCR (n = 6 day 0, n = 3 others). Immunohistochemical staining for IL-33 in the brains of Il33−/−, wild-type sham or wild-type ischaemic mice on day 14 after stroke onset. Data are representative of two independent experiments. b, Flow cytometric analysis of ST2 in the ischaemic brains of wild-type, Il33−/−, or Il1rl1−/− mice on day 14 after stroke onset. The frequency of ST2+ cells of Treg cells was determined (n = 3). Data are representative of two independent experiments. c, Flow cytometric analysis of the frequency of Treg cells among CD4+ T cells from the ischaemic mice administrated with anti-ST2 antibody on days 7, 10 and 12, and analysed on day 14 after stroke onset. The frequency of Treg cells of CD4+ T cells was determined (n = 5 control IgG-treated mice, n = 4 ST2 antibody-treated mice). Data are representative of a single experiment. d, Flow cytometric analysis of the frequency of ST2+ cells among brain cells from the ischaemic mice on day 14 after stroke onset. (n = 4). Data are representative of two independent experiments. e, Treg cells (1 × 106) from spleens and lymph nodes from wild-type or Il1rl1−/− mice were transferred into Rag2−/− mice on day 5 after stroke onset. The representative plots of CD4+ cells from the indicated tissues in the ischaemic brains on day 14. Data are representative of two independent experiments and shown as mean ± s.e.m. P values determined by two-tailed Student’s t-test.